Buy Outlook Therapeutics Inc - Warrants - Series A (18/02/2022) Stock | OTLKW Stock Price & Latest News | Public.com
OTLKW

Outlook Therapeutics Inc - Warrants - Series A (18/02/2022)

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Outlook Therapeutics Inc - Warrants - Series A (18/02/2022) (OTLKW) stock trends here

    About OTLKW

    Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification, development, manufacture, and commercialization of ONS-5010/LYTENAVA as the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal in...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Stats

    Market Cap
    Volume50,95k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High
    1 Year Low
    Open$1.03
    High$1.06
    Low$0.90

    Buy any stock with any amount of money.

    Download the App
    Download the app